Genetic variation at glucose and insulin trait loci and response to glucose-insulin-potassium (GIK) therapy: The IMMEDIATE trial

K. L. Ellis; Y. Zhou; J. R. Beshansky; E. Ainehsazan; Y. Yang; H. P. Selker; G. S. Huggins; L. A. Cupples; I. Peter

doi:10.1038/tpj.2014.41

Genetic variation at glucose and insulin trait loci and response to glucose-insulin-potassium (GIK) therapy: The IMMEDIATE trial

K. L. Ellis, Y. Zhou, J. R. Beshansky, E. Ainehsazan, Y. Yang, H. P. Selker, G. S. Huggins, L. A. Cupples, I. Peter

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Abstract

The mechanistic effects of intravenous glucose, insulin and potassium (GIK) in cardiac ischemia are not well understood. We conducted a genetic sub-study of the Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency care (IMMEDIATE) Trial to explore effects of common and rare glucose and insulin-related genetic loci on initial to 6-h and 6- to 12-h change in plasma glucose and potassium. We identified 27 NOTCH2/ADAM30 and 8 C2CD4B variants conferring a 40-57% increase in glucose during the first 6 h of infusion (P<5.96 × 10^-6). Significant associations were also found for ABCB11 and SLC30A8 single-nucleotide polymorphisms (SNPs) and glucose responses, and an SEC61A2 SNP with a potassium response to GIK. These studies identify genetic factors that may impact the metabolic response to GIK, which could influence treatment benefits in the setting of acute coronary syndromes (ACS).

Original language	English
Pages (from-to)	55-62
Number of pages	8
Journal	Pharmacogenomics Journal
Volume	15
Issue number	1
DOIs	https://doi.org/10.1038/tpj.2014.41
State	Published - 28 Feb 2015

Access to Document

10.1038/tpj.2014.41

Cite this

@article{54a11543867444fe8902db39bd567667,

title = "Genetic variation at glucose and insulin trait loci and response to glucose-insulin-potassium (GIK) therapy: The IMMEDIATE trial",

abstract = "The mechanistic effects of intravenous glucose, insulin and potassium (GIK) in cardiac ischemia are not well understood. We conducted a genetic sub-study of the Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency care (IMMEDIATE) Trial to explore effects of common and rare glucose and insulin-related genetic loci on initial to 6-h and 6- to 12-h change in plasma glucose and potassium. We identified 27 NOTCH2/ADAM30 and 8 C2CD4B variants conferring a 40-57\% increase in glucose during the first 6 h of infusion (P<5.96 × 10-6). Significant associations were also found for ABCB11 and SLC30A8 single-nucleotide polymorphisms (SNPs) and glucose responses, and an SEC61A2 SNP with a potassium response to GIK. These studies identify genetic factors that may impact the metabolic response to GIK, which could influence treatment benefits in the setting of acute coronary syndromes (ACS).",

author = "Ellis, \{K. L.\} and Y. Zhou and Beshansky, \{J. R.\} and E. Ainehsazan and Y. Yang and Selker, \{H. P.\} and Huggins, \{G. S.\} and Cupples, \{L. A.\} and I. Peter",

note = "Publisher Copyright: {\textcopyright} 2015 Macmillan Publishers Limited.",

year = "2015",

month = feb,

day = "28",

doi = "10.1038/tpj.2014.41",

language = "English",

volume = "15",

pages = "55--62",

journal = "Pharmacogenomics Journal",

issn = "1470-269X",

publisher = "Springer Nature",

number = "1",

}

TY - JOUR

T1 - Genetic variation at glucose and insulin trait loci and response to glucose-insulin-potassium (GIK) therapy

T2 - The IMMEDIATE trial

AU - Ellis, K. L.

AU - Zhou, Y.

AU - Beshansky, J. R.

AU - Ainehsazan, E.

AU - Yang, Y.

AU - Selker, H. P.

AU - Huggins, G. S.

AU - Cupples, L. A.

AU - Peter, I.

PY - 2015/2/28

Y1 - 2015/2/28

N2 - The mechanistic effects of intravenous glucose, insulin and potassium (GIK) in cardiac ischemia are not well understood. We conducted a genetic sub-study of the Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency care (IMMEDIATE) Trial to explore effects of common and rare glucose and insulin-related genetic loci on initial to 6-h and 6- to 12-h change in plasma glucose and potassium. We identified 27 NOTCH2/ADAM30 and 8 C2CD4B variants conferring a 40-57% increase in glucose during the first 6 h of infusion (P<5.96 × 10-6). Significant associations were also found for ABCB11 and SLC30A8 single-nucleotide polymorphisms (SNPs) and glucose responses, and an SEC61A2 SNP with a potassium response to GIK. These studies identify genetic factors that may impact the metabolic response to GIK, which could influence treatment benefits in the setting of acute coronary syndromes (ACS).

AB - The mechanistic effects of intravenous glucose, insulin and potassium (GIK) in cardiac ischemia are not well understood. We conducted a genetic sub-study of the Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency care (IMMEDIATE) Trial to explore effects of common and rare glucose and insulin-related genetic loci on initial to 6-h and 6- to 12-h change in plasma glucose and potassium. We identified 27 NOTCH2/ADAM30 and 8 C2CD4B variants conferring a 40-57% increase in glucose during the first 6 h of infusion (P<5.96 × 10-6). Significant associations were also found for ABCB11 and SLC30A8 single-nucleotide polymorphisms (SNPs) and glucose responses, and an SEC61A2 SNP with a potassium response to GIK. These studies identify genetic factors that may impact the metabolic response to GIK, which could influence treatment benefits in the setting of acute coronary syndromes (ACS).

UR - https://www.scopus.com/pages/publications/84921887293

U2 - 10.1038/tpj.2014.41

DO - 10.1038/tpj.2014.41

M3 - Article

C2 - 25135348

AN - SCOPUS:84921887293

SN - 1470-269X

VL - 15

SP - 55

EP - 62

JO - Pharmacogenomics Journal

JF - Pharmacogenomics Journal

IS - 1

ER -

Genetic variation at glucose and insulin trait loci and response to glucose-insulin-potassium (GIK) therapy: The IMMEDIATE trial

Abstract

Access to Document

Fingerprint

Cite this